Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Moodys
Merck
McKesson
Baxter

Last Updated: March 26, 2023

Investigational Drug Information for Pictilisib


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Pictilisib?

Pictilisib is an investigational drug.

There have been 6 clinical trials for Pictilisib. The most recent clinical trial was a Phase 2 trial, which was initiated on January 20th 2012.

The most common disease conditions in clinical trials are Breast Neoplasms, Gliosarcoma, and Glioblastoma. The leading clinical trial sponsors are Genentech, Inc., Roche Pharma AG, and Royal Marsden NHS Foundation Trust.

Recent Clinical Trials for Pictilisib
TitleSponsorPhase
PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclibInstitute of Cancer Research, United KingdomPhase 1
PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclibPfizerPhase 1
PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclibRoche Pharma AGPhase 1

See all Pictilisib clinical trials

Clinical Trial Summary for Pictilisib

Top disease conditions for Pictilisib
Top clinical trial sponsors for Pictilisib

See all Pictilisib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Moodys
Merck
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.